ORIFARM GENERICS A/S
CVR 25674030 · Public limited company (A/S) · Active · Low risk
ORIFARM GENERICS A/S is a Public limited company (A/S), founded on , based in Odense S. The company is registered in the industry engroshandel med læge- og hospitalsartikler. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.1 times the average for Danish companies. 20 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 496.3m and a net result of DKK 77.2m.
Bankruptcy risk for ORIFARM GENERICS A/S
0.1 × the average (1.41%) · higher risk than 38% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 25674030
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (26 years)
- Address
- Energivej 15
5260 Odense S - Municipality
- Odense
- Industry
- Engroshandel med læge- og hospitalsartikler (464620)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr - Share capital
- DKK 1.0m
- Employees
- 103 (2018)
- Auditor
- DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 1 of 25 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 39.4% |
| Current ratio | 160% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 1 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 31 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Revenue | DKK 2.5bn | DKK 2.3bn |
| Gross profit | DKK 399.8m | DKK 362.0m |
| Net profit | DKK 77.2m | DKK 59.9m |
| Equity | DKK 496.3m | DKK 554.5m |
| Total assets | DKK 1.3bn | DKK 1.0bn |
| Cash | DKK 171k | – |
| Short-term debt | DKK 751.4m | – |
| Tax owed | DKK 23.2m | – |
| Avg. employees | 247 | – |
Latest annual report: Reporting class C, stor virksomhed · auditor's statement: Revisionspåtegning · Deloitte Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 148 | ||
| 1 Jan 2024 – 31 Dec 2024 | 163 | ||
| 1 Jan 2023 – 31 Dec 2023 | 162 | ||
| 1 Jan 2022 – 31 Dec 2022 | 158 | ||
| 1 Jan 2021 – 31 Dec 2021 | 186 | Late | |
| 1 Jan 2020 – 31 Dec 2020 | 165 | ||
| 1 Jan 2019 – 31 Dec 2019 | 177 | ||
| 1 Jan 2018 – 31 Dec 2018 | 151 | ||
| 1 Jan 2017 – 31 Dec 2017 | 151 | ||
| 1 Jan 2016 – 31 Dec 2016 | 151 | ||
| 1 Jan 2015 – 31 Dec 2015 | 155 | ||
| 1 Jan 2014 – 31 Dec 2014 | 149 | ||
| 1 Jan 2013 – 31 Dec 2013 | 150 | ||
| 1 Jan 2012 – 31 Dec 2012 | 157 | ||
| 1 Jan 2011 – 31 Dec 2011 | 159 | ||
| 1 Jan 2010 – 31 Dec 2010 | 159 | ||
| 1 Jan 2009 – 31 Dec 2009 | 154 | ||
| 1 Jan 2008 – 31 Dec 2008 | 158 | ||
| 1 Jan 2007 – 31 Dec 2007 | 160 | ||
| 1 Jan 2006 – 31 Dec 2006 | 151 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Peter Andreas Stakemann | ||
| Board | Hans Carl Bøgh-Sørensen | Current | |
| Board | Birgitte Bøgh-Sørensen | Current | |
| Board | Thomas Brandhof | Current | |
| Board | Mads Fink Eriksen | Current | |
| Board | Nicki Lund Kristensen | Current | |
| Board | Kim Madsen | ||
| Board | Peter Andreas Stakemann | ||
| Board | Annemette Heller | ||
| Board | Ole Michael Friis | ||
| Board | Niels Thorborg | ||
| Board | Hans Carl Bøgh-Sørensen | ||
| Board | Per Munk Laustsen | ||
| Board | Ulrik Kronborg Markussen | ||
| Board | Ole Ibsen | ||
| Board | Hans Christian Eberhard Groth Teisen | ||
| Board | Erik Sandberg | ||
| Board | Dennis Dencher | ||
| Owner (100%) | ORIFARM GENERICS HOLDING A/S | Current | |
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Auditor | ERNST & YOUNG DENMARK P/S | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Founder | ANPARTSSELSKABET STAKEMANN | Current |
The CEOs' other companies
Peter Andreas Stakemann – 54 other companies, of which 54 bankrupt
- 01-05-24 ApS Bankrupt 17 Mar 2025
- 061746M A/S Bankrupt 3 Oct 2011
- 1 STEP, COPENHAGEN LOGISTIC & DISTRIBUTION ApS Bankrupt 15 Jan 2009
- 1001 WATT ApS Bankrupt 29 Jan 2002
- 123 AF 04.07.2012 ApS Bankrupt 6 Aug 2012
- 1264 ApS Bankrupt 12 Jun 2012
- 1414 EJENDOMSINVEST 10 ApS Bankrupt 22 Dec 2015
- 1414 EJENDOMSINVEST 12 ApS Bankrupt 22 Dec 2015
- 1414 EJENDOMSINVEST ApS Bankrupt 19 Dec 2014
- 1414 INVEST ApS Bankrupt 22 Dec 2015
- 1WAY2PRINT A/S Bankrupt 24 Jul 2003
- 2 X KJAER DK ApS Bankrupt 18 Dec 2024
- 20220608 ApS Bankrupt 18 Jul 2022
- 23K ApS Bankrupt 17 Jan 2022
- 24237982 A/S Bankrupt 25 Apr 2012
- 2BU EJENDOMME ApS Bankrupt 11 Sep 2013
- 2BU HOLDING ApS Bankrupt 2 Oct 2013
- 2Tal enterprise A/S Bankrupt 28 Apr 2020
- 2V AMAGER SYD ApS Bankrupt 20 Dec 2000
- 3 SIGMA ApS Bankrupt 9 Jun 2005
- 30 08 61 71 ApS Bankrupt 1 Dec 2011
- 31. OKTOBER 2008 ApS Bankrupt 18 Sep 2009
- 32 67 71 93 ApS Bankrupt 16 Nov 2011
- 36087374 ApS Bankrupt 10 Jan 2017
- 365 Service Holding ApS Bankrupt 26 Nov 2020
- 365 Service Partner ApS Bankrupt 26 Nov 2020
- 39701804 ApS Bankrupt 14 Aug 2020
- 39704994 ApS Bankrupt 14 Aug 2020
- 3BH ApS Bankrupt 3 May 2019
- 3XE BYG ApS Bankrupt 11 Aug 2017
Address history (2 moves)
| Energivej 15, 5260 Odense S | |
| Energivej 15, 5260 Odense S | |
| c/o Advokatfirmaet Stakemann, Kronprinsessegade 18, 1306 København K |
Former names
| ORIFARM GENERICS A/S | – now |
| COPYFARM A/S | – |
| A/S PSE 38 NR. 2228 | – |
Employees per year
Other companies at the same address
- ACCO ApS Opløst
- ANHECO ApS Opløst
- Acco Capital ApS Active
- BBS CONSULT ApS Opløst
- CHUCO ApS Opløst
- HABICO A/S Active
- HABICO HOLDING A/S Active
- HABICO INVEST A/S Fusioneret
- HANDELSSELSKABET AF 5. JANUAR 2002 A/S Opløst
- HBS Capital ApS Active
- Habico Capital ApS Fusioneret
- Habico Invest A/S Active
- Habico Invest II ApS Active
- Habico Invest III ApS Opløst
- IQ Charter I A/S Active
- OMPAKNINGSSELSKABET AF 1. NOVEMBER 2005 A/S Opløst
- OPCO-PHARMA ApS Fusioneret
- ORIFARM A/S Active
- ORIFARM DISTRIBUTION A/S Opløst
- ORIFARM GENERICS HOLDING A/S Active
- ORIFARM GROUP A/S Active
- ORIFARM HOLDING A/S Fusioneret
- ORIFARM PI A/S Active
- ORIFARM PROPERTY A/S Active
- ORIFARM SUPPLY A/S Active
Similar companies in Odense
- Nisa Medical ApS Agedrup
- Nordic Medical Supply ApS Odense M
- LABLAB ApS Odense M
- MEDICODAN ApS Odense SØ
- ZENOUMED ApS Odense SØ
- MEDSHOP.DK ApS Odense NV
- FYNS DENTAL ApS Odense S
- Meditek Danmark ApS Odense S
- CuraTec Nordic ApS Odense SV
- Promedico PLUS ApS Odense SØ
- Odense Røntgenservice ApS Odense S
- Stetoshop IVS Odense C
Questions and answers about ORIFARM GENERICS A/S
Has ORIFARM GENERICS A/S gone bankrupt?
No, ORIFARM GENERICS A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of ORIFARM GENERICS A/S?
Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.1 times the average for Danish companies.
Who is the auditor of ORIFARM GENERICS A/S?
ORIFARM GENERICS A/S most recently used DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was ORIFARM GENERICS A/S founded?
ORIFARM GENERICS A/S was founded on 15 October 2000.
What is the equity of ORIFARM GENERICS A/S?
Equity was DKK 496.3m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.